At present, a large number of studies have proven that the lipopolysaccharide (LPS)/Toll-like receptor 4 (TLR4) signaling pathway plays an important role in chronic inflammatory diseases and that chronic inflammation is closely related to tumor development (Li et al. 2017, 2019). The gene discussed is TLR4; the disease is neoplasm.